These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 26739444)

  • 1. Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.
    Hu Y; Zhao Q; Werngren J; Hoffner S; Diwan VK; Xu B
    BMC Infect Dis; 2016 Jan; 16():4. PubMed ID: 26739444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
    Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
    BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24 loci MIRU-VNTR analysis and pattern of drug resistance in pre-extensively drug resistant pulmonary tuberculosis in Bangladesh.
    Monir BB; Sultana SS; Tarafder S
    Infect Genet Evol; 2022 Aug; 102():105304. PubMed ID: 35595025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China.
    Zhang J; Mi L; Wang Y; Liu P; Liang H; Huang Y; Lv B; Yuan L
    BMC Res Notes; 2012 Jun; 5():309. PubMed ID: 22713520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.
    Wang XH; Ma AG; Han XX; Gu XM; Fu LP; Li PG; Li FY; Wang QZ; Liang H; Katar A; Wang LJ
    Med Sci Monit; 2015 May; 21():1313-8. PubMed ID: 25950148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic profiling of Mycobacterium tuberculosis revealed "modern" Beijing strains linked to MDR-TB from Southwestern Colombia.
    Nieto Ramirez LM; Ferro BE; Diaz G; Anthony RM; de Beer J; van Soolingen D
    PLoS One; 2020; 15(4):e0224908. PubMed ID: 32330146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
    Said HM; Kock MM; Ismail NA; Mphahlele M; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    J Clin Microbiol; 2012 Sep; 50(9):2857-62. PubMed ID: 22649019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
    Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
    Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
    Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
    Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
    Kateete DP; Kamulegeya R; Kigozi E; Katabazi FA; Lukoye D; Sebit SI; Abdi H; Arube P; Kasule GW; Musisi K; Dlamini MG; Khumalo D; Joloba ML
    BMC Pulm Med; 2019 Jul; 19(1):124. PubMed ID: 31291943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Merker M; Nikolaevskaya E; Kohl TA; Molina-Moya B; Pavlovska O; Brännberg P; Dudnyk A; Stokich V; Barilar I; Marynova I; Filipova T; Prat C; Sjöstedt A; Dominguez J; Rzhepishevska O; Niemann S
    Emerg Infect Dis; 2020 Mar; 26(3):481-490. PubMed ID: 32091369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
    Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution and transmission patterns of extensively drug-resistant tuberculosis in China.
    Wang F; Shao L; Fan X; Shen Y; Diao N; Jin J; Sun F; Wu J; Chen J; Weng X; Cheng X; Zhang Y; Zhang W
    Antimicrob Agents Chemother; 2015 Feb; 59(2):818-25. PubMed ID: 25403663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
    Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
    BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First insights into the genetic characteristics and drug resistance of Mycobacterium tuberculosis population collected during the first national tuberculosis prevalence survey of Lao PDR (2010-2011).
    Somphavong S; Berland JL; Gauthier M; Vu TT; Nguyen QH; Iem V; Vongvichit P; Inthavong D; Akkhavong V; Chanthavilay P; Soundala S; Keovichit I; Paranhos-Baccalà G; Paboriboune P; Nguyen TVA; Bañuls AL
    BMC Infect Dis; 2019 Oct; 19(1):851. PubMed ID: 31615439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.